Keywords: wyeth, withdraws, european, maa, pristiq, menopausal, hot

Wyeth withdraws European MAA for Pristiq in menopausal hot flashes

Article | 17 March 2008

US drug major Wyeth has withdrawn its application for a European centralized marketing application for Pristiq (desvenlafaxine) 50mg and 100mg ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Wyeth

Go to company listing

Related Drugs

Desvenlafaxine Extended-Release Tablets

Pristiq

Go to drug listing